QSimulate Receives $2.5 Million in a New Funding Round

Quantum Simulation Technologies, Inc. (QSimulate) has secured $2.5M in funding from 2xN, UTokyo IPC, and Kyoto iCAP. The investment will bolster QSimulate’s business, which focuses on its quantum physics-based drug-discovery platform, QSP Life. This platform includes QUELO, QuValent, and QuantumFP, which cover various aspects of drug design. QSimulate employs proprietary quantum physics-based algorithms to predict […]

The post QSimulate Receives $2.5 Million in a New Funding Round appeared first on Quantum Computing Report.